Results 251 to 260 of about 27,268 (276)

Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia

Journal of Clinical Endocrinology and Metabolism, 2022
Agnès Linglart, Erik A Imel, Michael P Whyte   +2 more
exaly  

DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis

Nature Genetics, 2006
Murat Bastepe, Feliciano J Ramos, Miikka Vikkula   +2 more
exaly  

X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment

Endocrine Reviews, 2018
Yuka Kinoshita, Seijii Fukumoto
exaly  

HEREDITARY HYPOPHOSPHATEMIA

Archives of Pediatrics & Adolescent Medicine, 1967
openaire   +2 more sources

A clinician's guide to X-linked hypophosphatemia

Journal of Bone and Mineral Research, 2011
Thomas O Carpenter, Erik A Imel, Karl L Insogna   +2 more
exaly  

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Journal of Bone and Mineral Research, 2018
Karl L Insogna, Karine Briot, Erik A Imel   +2 more
exaly  

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

Matrix Biology, 2004
Despina Sitara, Mohammed S Razzaque, Reinhold G Erben   +2 more
exaly  

Carbohydrate Induced Hypophosphatemia

Acta Anaesthesiologica Scandinavica, 1985
openaire   +3 more sources

Clinical Hypophosphatemia

Annual Review of Medicine, 1978
openaire   +2 more sources

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial

Journal of Bone and Mineral Research, 2019
Karl L Insogna, Frank Rauch, Peter Kamenický   +2 more
exaly